NCT06937385View on ClinicalTrials.gov

0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
HeadacheMigraineTension HeadacheOccipital Neuralgia
Interventions
DRUG

0.5% Bupivacaine HCl

bilateral cervical injections of 0.5% bupivacaine into the paraspinous muscle at the c6-7 location for headache treatment

DRUG

standard IV treatment for headache

physicians choice of IV medications in treatment of headache

Trial Locations (1)

32605

HCA Florida north florida Hospital, Gainesville

All Listed Sponsors
lead

HCA Florida North Florida Hospital

OTHER